News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13,099 Results
Type
Article (282)
Press Release (12819)
Section
Business (6939)
Career Advice (6)
Deals (826)
Drug Development (801)
FDA (122)
Job Trends (280)
News (7792)
Policy (199)
Tag
Academia (13)
Accelerated approval (2)
ADA (1)
Allergies (2)
Alliances (199)
ALS (2)
Alzheimer's disease (22)
Antibody-drug conjugate (ADC) (17)
Approvals (149)
Artificial intelligence (8)
ASCO (8)
Autoimmune disease (10)
Bankruptcy (3)
Best Places to Work (284)
Biosimilars (3)
Bladder cancer (7)
Brain cancer (2)
Breast cancer (17)
Cancer (159)
Cardiovascular disease (12)
Career advice (6)
CAR-T (2)
CDMO (1)
Cell therapy (25)
Cervical cancer (1)
Clinical research (831)
Collaboration (26)
Compensation (24)
COVID-19 (21)
CRISPR (1)
C-suite (7)
Cystic fibrosis (3)
Data (227)
Depression (5)
Dermatology (5)
Diabetes (21)
Diagnostics (136)
Digital health (3)
Drug discovery (4)
Drug pricing (1)
Duchenne muscular dystrophy (2)
Earnings (7753)
Events (654)
Executive appointments (3)
FDA (273)
Frontotemporal dementia (4)
Funding (16)
Gene editing (4)
Generative AI (1)
Gene therapy (5)
GLP-1 (37)
Government (30)
Guidances (100)
Healthcare (406)
Hematology (2)
HIV (6)
IgA nephropathy (2)
Immunology and inflammation (6)
Immuno-oncology (16)
Indications (6)
Infectious disease (24)
Inflammatory bowel disease (1)
Intellectual property (3)
IPO (738)
Job creations (19)
Job search strategy (5)
JPM (1)
Labor market (1)
Layoffs (9)
Legal (26)
Liver cancer (5)
Lung cancer (30)
Lymphoma (7)
Machine learning (1)
Manufacturing (7)
Marketing (1)
MASH (12)
Medical device (318)
Medtech (326)
Mergers & acquisitions (95)
Metabolic disorders (55)
mRNA (5)
Neurodegenerative disease (7)
Neuropsychiatric disorders (4)
Neuroscience (42)
NextGen: Class of 2026 (64)
Non-profit (26)
Obesity (25)
Opinion (1)
Ovarian cancer (6)
Pain (3)
Pancreatic cancer (6)
Parkinson's disease (4)
Patents (5)
Patient recruitment (9)
Peanut (2)
People (130)
Phase 1 (179)
Phase 2 (313)
Phase 3 (407)
Pipeline (728)
Postmarket research (36)
Preclinical (65)
Press Release (1)
Prostate cancer (8)
Radiopharmaceuticals (17)
Rare diseases (18)
Real estate (17)
Regulatory (216)
Reports (3)
Research institute (11)
Resumes & cover letters (1)
Rett syndrome (1)
RSV (2)
Schizophrenia (4)
Series A (2)
Series B (5)
Sickle cell disease (1)
Special edition (1)
Spinal muscular atrophy (6)
Sponsored (2)
Startups (9)
Supply chain (1)
Vaccines (6)
Venture capital (2)
Weight loss (22)
Women's health (6)
Date
Today (1)
Last 7 days (6)
Last 30 days (31)
Last 365 days (943)
2026 (694)
2025 (946)
2024 (1033)
2023 (1052)
2022 (2628)
2021 (1391)
2020 (996)
2019 (689)
2018 (604)
2017 (390)
2016 (208)
2015 (300)
2014 (224)
2013 (94)
2012 (148)
2011 (234)
2010 (199)
Location
Africa (8)
Alabama (1)
Arizona (6)
Asia (708)
Australia (43)
California (449)
Canada (98)
China (31)
Colorado (22)
Connecticut (23)
Delaware (21)
Europe (1495)
Florida (74)
Georgia (18)
Illinois (39)
India (1)
Indiana (40)
Japan (29)
Kansas (2)
Kentucky (3)
Louisiana (5)
Maine (7)
Maryland (60)
Massachusetts (391)
Michigan (18)
Minnesota (26)
Missouri (7)
Nevada (4)
New Hampshire (4)
New Jersey (130)
New York (143)
North Carolina (69)
Northern California (275)
Ohio (12)
Pennsylvania (92)
Rhode Island (1)
South America (18)
South Carolina (2)
Southern California (159)
Tennessee (2)
Texas (50)
United States (1738)
Utah (19)
Virginia (6)
Washington D.C. (1)
Washington State (26)
Wisconsin (7)
13,099 Results for "137".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
AusperBio Completes $120 Million Series C Financing to Advance AHB-137 Toward Potential Commercialization and Expand Next-Generation HBV Therapies
August 27, 2026
·
6 min read
Press Releases
New scientific Article Published on TrkA-NAM ACD137 Against Osteoarthritic Pain
May 6, 2026
·
4 min read
Funding
Novartis-backed Sidewinder collects $137M series B to strike at difficult-to-treat tumors
Sidewinder Therapeutics’ bispecific antibody-drug conjugates target pairs of receptors found on cancer cells, which the company claims improves their specificity and minimizes off-target effects.
April 9, 2026
·
2 min read
·
Tristan Manalac
Press Releases
NETRIS Pharma: Nature publishes positive pancreatic cancer Phase 1b data for NP137 anti-netrin-1 monoclonal antibody
April 23, 2026
·
9 min read
Press Releases
AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain
May 19, 2026
·
4 min read
Press Releases
Sidewinder Therapeutics Announces $137 Million Series B Financing to Advance Precision Bispecific ADCs into Clinical Development for Cancer
April 8, 2026
·
3 min read
Press Releases
AusperBio Completes Patient Enrollment in Phase III AUSHINE Study of AHB-137 for Chronic Hepatitis B
December 23, 2025
·
5 min read
Press Releases
Ankyra Therapeutics Presents First Preclinical Data on ANK-203, a Novel CD137-Anchored Immunotherapy Candidate, in Oral Session at AACR IO
February 18, 2026
·
3 min read
Press Releases
AusperBio Announces Late-Breaking 48-Week Phase II Data of AHB-137 in Chronic Hepatitis B at AASLD 2025
November 10, 2025
·
3 min read
Press Releases
AusperBio Announces AHB-137 Monotherapy Achieved 30% Functional Cure Rate in HBe-negative CHB Patients on Stable Nucleos(t)ide Analogue (NA) Therapy
December 15, 2025
·
5 min read
1 of 1,310
Next
